Crowley Elizabeth

Track

Insider profile

Performance

Overall performance
1.7
Performance over holding periods
1.7
30 days 90 days 120 days
Average return -13% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Crowley Elizabeth's trades of Celldex Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-18 2024-06-14
S Sale
65,812 -12.1%
295.02
US$1,674,264 		65,812 -12.1% 295.02 US$1,674,264
2024-06-14 2024-06-14
PrS Proposed sale
59,058
458.68
US$4,658,863 		59,058 458.68 US$4,658,863
2024-06-11 2024-06-07
S Sale
11,146 -16.1%
324.42
US$2,091,613 		11,146 -16.1% 324.42 US$2,091,613
2024-06-07 2024-06-07
PrS Proposed sale
15,000
34.00
US$510,000 		15,000 34.00 US$510,000
2024-06-03 2024-05-30
S Sale
38,597 -81.0%
33.64
US$1,298,384 		38,597 -81.0% 33.64 US$1,298,384
2024-05-30 2024-05-30
PrS Proposed sale
38,597
3.73
US$144,004 		38,597 3.73 US$144,004
2021-12-10 2021-12-08
PlS Planned sale
4,000 -45.8%
40.00
US$160,000 		4,000 -45.8% 40.00 US$160,000
2021-11-03 2021-11-01
PlS Planned sale
1,189 -20.1%
41.62
US$49,481 		1,189 -20.1% 41.62 US$49,481
2021-11-03 2021-11-01
PlS Planned sale
600 -9.2%
43.11
US$25,868 		600 -9.2% 43.11 US$25,868
2021-11-03 2021-11-01
PlS Planned sale
2,528 -28.0%
44.12
US$111,525 		2,528 -28.0% 44.12 US$111,525